- Sequential effect of multikinase inhibitors of biological treatment in patient with generalized renal cell carcinoma2010 | First Faculty of Medicine
- New options for biologically targeted therapy of advanced non-small-cell lung cancer - sunitinib and sorasfenib2010 | Central Library of Charles University
- Crizotinib - a novel multikinase inhibitor of signalling pathways for treatment in selected patients with non-small cell lung cancwer2013 | Faculty of Medicine in Pilsen
- Utility design NEXCREAM no. 19655Publication without faculty affiliation
- Prototype NEXCREAM - due to utility design no. 19655Publication without faculty affiliation
- Proven technology NEXCREAM ? company standard PN OT ? 02-2009 due to utility design no. 19655Publication without faculty affiliation
- Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study2015 | First Faculty of Medicine
- The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.2010 | Faculty of Medicine in Pilsen
- New possibilities of systemic treatment of thyroid cancer2018 | Publication without faculty affiliation
- Recent advances in immunotherapy for metastatic colorectal cancer2023 | Publication without faculty affiliation
- Lonsurf plus bevacizumab: A new standard in the third-line treatment of metastatic colorectal carcinoma2023 | Publication without faculty affiliation
- Renal cell carcinoma 20152015 | First Faculty of Medicine
- Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer2023 | Publication without faculty affiliation